Press Releases

Date Title and Summary Additional Formats
Toggle Summary ArQule Announces Date Change of 2008 Annual Meeting of Stockholders to May 15, 2008
ArQule Announces Date Change of 2008 Annual Meeting of Stockholders to May 15, 2008 WOBURN, Mass.--(BUSINESS WIRE)--April 14, 2008--ArQule, Inc. (NASDAQ: ARQL) today announced that its 2008 annual meeting of stockholders will be held on May 15, 2008, instead of May 16, 2008, as previously announced
View HTML
Toggle Summary ArQule Summarizes Abstracts Presented at AACR
Pre-clinical findings support novel approaches to cancer therapy
View HTML
Toggle Summary ArQule Provides Clinical Update on E2F-1 Program
ArQule Provides Clinical Update on E2F-1 Program WOBURN, Mass., Apr 10, 2008 (BUSINESS WIRE) -- ArQule, Inc. (NASDAQ: ARQL) today announced the completion of its previously disclosed analysis of QTc prolongation data related to a Phase 1 dose escalation trial with ARQ 171, a second generation
View HTML
Toggle Summary ArQule Provides Clinical Update on E2F-1 Program
ArQule Provides Clinical Update on E2F-1 Program WOBURN, Mass., Apr 10, 2008 (BUSINESS WIRE) -- ArQule, Inc. (NASDAQ: ARQL) today announced the completion of its previously disclosed analysis of QTc prolongation data related to a Phase 1 dose escalation trial with ARQ 171, a second generation
View HTML
Toggle Summary ArQule Announces Receipt of Milestone Payment from Wyeth
ArQule Announces Receipt of Milestone Payment from Wyeth WOBURN, Mass.--(BUSINESS WIRE)--March 26, 2008--ArQule, Inc. (NASDAQ: ARQL) today announced the receipt of a milestone payment from Wyeth (NYSE:WYE) in connection with the filing of an Investigational New Drug (IND) application by Wyeth to
View HTML
Toggle Summary ArQule Enrolls First Patient in Phase 1/2 Clinical Trial Program of ARQ 197 in Non-Small Cell Lung Cancer
Trial marks third clinical indication for Company's c-Met inhibitor
View HTML
Toggle Summary ArQule, Inc. to Present at Susquehanna Financial Group Conference on March 5, 2008
Live web cast scheduled for 11:00 a.m. eastern time
View HTML
Toggle Summary ArQule Reports Fiscal 2007 Year End and Fourth Quarter Results
Conference call scheduled today at 9:00 a.m. eastern time
View HTML
Toggle Summary ArQule Receives $3 Million Milestone from Kyowa Hakko
Payment marks initiation of Phase 1 clinical trial with ARQ 197 in Asia
View HTML
Toggle Summary ArQule to Report Fiscal 2007 Financial Results on February 7, 2008
Conference call and web cast scheduled for 9:00 a.m. eastern time
View HTML

Questions or Concerns?

Please feel free to contact by one of the methods below

Online Form   Call (781) 994-0300

These archived presentations and related materials are provided for reference by ArQule, Inc. Information contained in the materials was current only as of the date of the event. ArQule, Inc. does not update or delete outdated information contained in these materials, and it expressly disclaims any obligation to do so. The materials are property of ArQule, Inc. and any use, dissemination or republication of the files is prohibited without the express written consent of ArQule, Inc.